This is a discussion on TA151: Diabetes - insulin pump therapy within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Diabetes - insulin pump therapy . It links to the published guidance and key ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA53: Diabetes (types 1 and 2) - long acting insulin analogues | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA113: Diabetes (type 1 and 2) - inhaled insulin | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| Disetronic Medical Systems Inc.Announces a recall of the ACCU-CHEK Spirit insulin pump due to "up" and/or "down" butto | industry_news | FDA Recalls, Market Withdrawals and Safety Alerts | 0 | 04-30-2009 04:38 PM |
| Inhaled Human Insulin Causes Small Changes in Pulmonary Function in Type 2 Diabetes | industry_news | Other Clinical Pharmacy News | 0 | 08-29-2008 03:31 PM |
| Colesevelam May Be Safe, Effective in Patients With Diabetes Receiving Insulin | industry_news | Other Clinical Pharmacy News | 0 | 07-29-2008 09:37 PM |